Table 1.
Study | Did study include a comparison group?a | Was the trial randomized? | Was the randomization procedure described and was it appropriate? | Was the treatment allocation concealed? | Were groups similar at baseline on prognostic indicators? | Were blind outcome assessments conducted? | Was the number of withdrawals/dropouts in each group mentioned? | In addition to stating the number of withdrawals/dropouts, were reasons given for each group? | Was an analysis conducted on the intention-to-treat sample? | Was a power calculation described? | Jadad score (revised, maximum score = 4) |
---|---|---|---|---|---|---|---|---|---|---|---|
Bazarko et al. (2013) | No | No | No | No | No | No | Yes | No | No | No | 0 |
Beaumont et al. (2016b) a | No | No | No | No | No | No | No | No | No | No | 0 |
Beaumont et al. (2016b) b | No | No | No | No | No | No | No | No | No | No | 0 |
Beaumont (2016b) c | No | No | No | No | No | No | No | No | No | No | 0 |
Beck et al. (2017) | Yes | Yes | No | No | Yes | No | No | No | No | No | 1 |
Bond et al. (2013) | No | No | No | No | No | No | Yes | No | No | No | 0 |
Brooker et al. (2013) | No | No | No | No | No | No | Yes | No | No | No | 0 |
Crowder and Sears (2017) | Yes | Yes | No | No | Yes | No | Yes | No | No | No | 1 |
Danilewitz et al. (2016) | Yes | Yes | No | No | Yes | No | Yes | No | No | No | 1 |
Duarte and Pinto-Gouveia (2016) | Yes | No | No | No | Yes | Yes | Yes | Yes | No | No | 2 |
Erogul et al. (2014) | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | No | Yes | 4 |
Finlay-Jones et al. (2017) | No | No | No | No | No | No | Yes | No | No | Yes | 0 |
Irving (2011) | No | No | No | No | No | No | Yes | Yes | No | No | 1 |
Lopes et al. (2018) | No | No | No | No | No | No | Yes | No | No | Yes | 0 |
Marx et al. (2014) | No | No | No | No | No | No | Yes | Yes | No | No | 1 |
Mathad et al. (2017) | Yes | Yes | No | No | Yes | No | Yes | Yes | No | Yes | 2 |
Pakenham (2015) | No | No | No | No | No | No | Yes | No | No | No | 0 |
Penque (2009) | No | No | No | No | No | No | Yes | Yes | No | Yes | 1 |
Raab et al. (2015) | No | No | No | No | No | No | No | No | No | No | 0 |
Rao and Kemper (2017) | No | No | No | No | No | No | No | No | No | No | 0 |
Rimes and Wingrove (2011) | No | No | No | No | No | No | Yes | Yes | No | No | 1 |
Rodrigues et al. (2018) | No | No | No | No | No | No | Yes | Yes | No | No | 1 |
Romcevich et al. (2018) | No | No | No | No | No | No | Yes | No | No | No | 0 |
Runyan et al. (2016) | No | No | No | No | No | No | Yes | No | No | Yes | 0 |
Scarlet et al. (2017) | No | No | No | No | No | No | Yes | Yes | No | No | 1 |
Shapiro et al. (2007) | Yes | No | No | No | Yes | No | Yes | No | No | No | 0 |
Shapiro et al. (2005) | Yes | Yes | No | No | No | No | Yes | Yes | No | No | 2 |
Slatyer et al. (2017) | Yes | No | No | No | Yes | No | Yes | Yes | No | Yes | 1 |
Stafford-Brown and Pakenham (2012) | Yes | No | No | No | Yes | No | Yes | Yes | Yes | No | 1 |
Verweij et al. (2017) | Yes | Yes | Yes | No | Yes | No | Yes | Yes | Yes | Yes | 3 |
Columns in italics constitute the revised Jadad Scale
aNot part of Jadad scale, supplemented to provide context for scores